A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes

被引：0
|
作者：
Andreas Andersen
Filip Krag Knop
Tina Vilsbøll
机构：
[1] University of Copenhagen,Steno Diabetes Center Copenhagen, Gentofte Hospital
[2] University of Copenhagen,Center for Clinical Metabolic Research, Gentofte Hospital
[3] University of Copenhagen,Department of Clinical Medicine, Faculty of Health and Medical Sciences
[4] University of Copenhagen,Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences
来源：
Drugs | 2021年 / 81卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1003 / 1030
页数：27
相关论文
共 50 条
  • [21] Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes reply
    Husain, Mansoor
    Donsmark, Morten
    Bain, Stephen C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 2076 - 2077
  • [22] CLINICAL EXPERIENCES OF TYPE 2 DIABETES (T2DM) PATIENTS INITIATING ORAL SEMAGLUTIDE
    Dunn, T. J.
    Swift, C.
    Guesnier, A.
    Noone, J.
    Willey, V
    VALUE IN HEALTH, 2022, 25 (07) : S309 - S309
  • [23] Semaglutide injection for the treatment of adults with type 2 diabetes
    Chudleigh, Richard A.
    Bain, Stephen C.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (07) : 675 - 683
  • [24] Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes
    Guzauskas, Gregory F.
    Rind, David M.
    Fazioli, Katherine
    Chapman, Richard H.
    Pearson, Steven D.
    Hansen, Ryan N.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (04): : 455 - 468
  • [25] Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes A Randomized Clinical Trial
    Davies, Melanie
    Pieber, Thomas R.
    Hartoft-Nielsen, Marie-Louise
    Hansen, Oluf K. H.
    Jabbour, Serge
    Rosenstock, Julio
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (15): : 1460 - 1470
  • [26] Semaglutide and Type 2 diabetes
    Malbos, Damien
    ACTUALITES PHARMACEUTIQUES, 2021, 60 (608): : 5 - 5
  • [27] Pharmacological treatment of type 2 diabetes
    Hermans, MP
    Buysschaert, M
    ACTA CLINICA BELGICA, 2004, 59 (02) : 59 - 66
  • [28] A Peptide in a Pill-Oral Semaglutide in the Management of Type 2 Diabetes
    Selvarajan, Raja
    Subramanian, Rashmi
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 1709 - 1720
  • [29] Remission of type 2 diabetes with the oral combo semaglutide plus dapagliflozin
    Lunati, M. E.
    Cimino, V.
    Lazzaroni, E.
    Montefusco, L.
    Pastore, I.
    Morpurgo, P. S.
    Gandolfi, A.
    Tinari, C.
    Rossi, A.
    Zuccotti, G.
    Fiorina, P.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S339 - S339
  • [30] Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
    Pearson, Sam
    Kietsiriroje, Noppadol
    Ajjan, Ramzi A.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 2515 - 2529
12345